XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock Class A
Common Stock
Common Stock Class A
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023     181,945,771      
Beginning balance at Dec. 31, 2023 $ 9,732,552   $ 182 $ 14,797,723 $ 619 $ (5,065,972)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (96,933)         (96,933)
Exercises of vested stock options (in shares)     114,995      
Exercises of vested stock options 2,068     2,068    
Vesting of restricted stock units (in shares)     4,893,903      
Vesting of restricted stock units 0   $ 5 (5)    
Value of equity awards withheld for tax liability (in shares)     (27,839)      
Value of equity awards withheld for tax liability (1,981)     (1,981)    
Shares issued under ESPP (in shares)     394,479      
Shares issued under ESPP 20,601     20,601    
Shares of Class A common stock issued and donated to charity (in shares)     66,306      
Shares of Class A common stock issued and donated to charity 3,911     3,911    
Shares returned from escrow (in shares)     (696)      
Shares returned from escrow (192)     (192)    
Unrealized gain (loss) on marketable securities 22,303       22,303  
Repurchases of shares of Class A common stock including related costs (in shares)     (32,000,610)      
Repurchases of shares of Class A common stock including related costs (1,931,989)   $ (32)     (1,931,957)
Net change in market value of effective foreign currency forward exchange contracts 1,285       1,285  
Share of other comprehensive income (loss) from equity method investment 188       188  
Stock-based compensation 477,054     477,054    
Ending balance (in shares) at Sep. 30, 2024     155,386,309      
Ending balance at Sep. 30, 2024 8,228,867   $ 155 15,299,179 24,395 (7,094,862)
Beginning balance (in shares) at Jun. 30, 2024     164,150,089      
Beginning balance at Jun. 30, 2024 8,679,473   $ 164 15,136,786 (10,671) (6,446,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (9,726)         (9,726)
Exercises of vested stock options (in shares)     43,562      
Exercises of vested stock options 969     969    
Vesting of restricted stock units (in shares)     1,813,439      
Vesting of restricted stock units 0   $ 2 (2)    
Value of equity awards withheld for tax liability (in shares)     (302)      
Value of equity awards withheld for tax liability (18)     (18)    
Shares of Class A common stock issued and donated to charity (in shares)     22,102      
Shares of Class A common stock issued and donated to charity 1,301     1,301    
Unrealized gain (loss) on marketable securities 29,317       29,317  
Repurchases of shares of Class A common stock including related costs (in shares)     (10,642,581)      
Repurchases of shares of Class A common stock including related costs (638,341)   $ (11)     (638,330)
Net change in market value of effective foreign currency forward exchange contracts 6,613       6,613  
Share of other comprehensive income (loss) from equity method investment (864)       (864)  
Stock-based compensation 160,143     160,143    
Ending balance (in shares) at Sep. 30, 2024     155,386,309      
Ending balance at Sep. 30, 2024 8,228,867   $ 155 15,299,179 24,395 (7,094,862)
Beginning balance (in shares) at Dec. 31, 2024   152,610,697 152,610,697      
Beginning balance at Dec. 31, 2024 7,952,966   $ 153 15,476,124 (1,301) (7,522,010)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 79,688         79,688
Exercises of vested stock options (in shares)     384,295      
Exercises of vested stock options 5,523     5,523    
Vesting of restricted stock units (in shares)     5,175,927      
Vesting of restricted stock units 0   $ 6 (6)    
Value of equity awards withheld for tax liability (in shares)     (1,665)      
Value of equity awards withheld for tax liability (213)     (213)    
Shares issued under ESPP (in shares)     253,298      
Shares issued under ESPP 20,757     20,757    
Shares of Class A common stock issued and donated to charity (in shares)     66,306      
Shares of Class A common stock issued and donated to charity 7,118     7,118    
Unrealized gain (loss) on marketable securities 5,941       5,941  
Repurchases of shares of Class A common stock including related costs (in shares)     (6,421,039)      
Repurchases of shares of Class A common stock including related costs (656,317)   $ (7)     (656,310)
Net change in market value of effective foreign currency forward exchange contracts 18,573       18,573  
Share of other comprehensive income (loss) from equity method investment (607)       (607)  
Stock-based compensation 461,860     461,860    
Ending balance (in shares) at Sep. 30, 2025   152,067,819 152,067,819      
Ending balance at Sep. 30, 2025 7,895,289   $ 152 15,971,163 22,606 (8,098,632)
Beginning balance (in shares) at Jun. 30, 2025     153,576,158      
Beginning balance at Jun. 30, 2025 8,043,922   $ 154 15,805,141 24,716 (7,786,089)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 37,248         37,248
Exercises of vested stock options (in shares)     27,071      
Exercises of vested stock options 373     373    
Vesting of restricted stock units (in shares)     1,832,097      
Vesting of restricted stock units 0   $ 2 (2)    
Value of equity awards withheld for tax liability (in shares)     (581)      
Value of equity awards withheld for tax liability (75)     (75)    
Shares of Class A common stock issued and donated to charity (in shares)     22,102      
Shares of Class A common stock issued and donated to charity 2,105     2,105    
Unrealized gain (loss) on marketable securities 1,999       1,999  
Repurchases of shares of Class A common stock including related costs (in shares)     (3,389,028)      
Repurchases of shares of Class A common stock including related costs (349,795)   $ (4)     (349,791)
Net change in market value of effective foreign currency forward exchange contracts (5,634)       (5,634)  
Share of other comprehensive income (loss) from equity method investment 1,525       1,525  
Stock-based compensation 163,621     163,621    
Ending balance (in shares) at Sep. 30, 2025   152,067,819 152,067,819      
Ending balance at Sep. 30, 2025 $ 7,895,289   $ 152 $ 15,971,163 $ 22,606 $ (8,098,632)